XML 23 R135.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Supplemental Financial Information - Quarterly Results (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]                        
Total revenues $ 68,907 $ 67,718 $ 66,293 $ 65,485 $ 67,867 $ 72,570 $ 74,775 $ 58,904   $ 268,403 $ 274,116 $ 228,295
Operating income 14,809 16,131 11,911 10,683 11,819 21,708 14,531 13,221   53,534 61,279 49,088
(Loss)/income before income taxes (22,355) 8,635 6,066 7,775 (12,597) 27,530 22,184 13,922   121 51,039 58,192
Net (loss)/income $ (25,880) $ 4,152 $ 2,479 $ 8,824 $ (11,564) $ 22,049 $ 16,724 $ 9,424   $ (10,425) $ 36,633 $ 27,199
(Loss)/earnings per share - basic $ (0.17) $ 0.02 $ 0.01 $ 0.05 $ (0.08) $ 0.13 $ 0.10 $ 0.07   $ (0.08) $ 0.23 $ 0.20
(Loss)/earnings per share - diluted (0.17) 0.02 0.01 0.05 (0.08) 0.13 0.10 0.07   (0.08) 0.23 0.20
Dividends per common share $ 0.03 $ 0.03 $ 0.03 $ 0.03 $ 0.03 $ 0.03 $ 0.03 $ 0.03   $ 0.12 $ 0.12 $ 0.32
(Loss)/gain on revaluation of deferred consideration (Note 12) $ (5,354) $ (6,306) $ (4,037) $ 4,404 $ (5,410) $ 7,732 $ 9,898   $ 12,220 $ (11,293) [1] $ 12,220 [1]  
Impairments (Note 26) $ (30,138) $ 0 $ 0 $ (572) $ (17,386)         $ (30,710) $ (17,386)  
[1] (Losses)/gains arise due to increases/(decreases) in the forward-looking price of gold and the magnitude of any gain or loss is highly correlated to the magnitude of the change in the forward-looking price of gold. See Note 5 for a reconciliation of changes in the deferred consideration balances